Form 4 for STTK Shattuck Labs, Inc.
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-10 · accession 0000899243-21-032549 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-11 | 2021-08-10 | STTK | Pandite Arundathy N. | Chief Medical Off | M - OptEx | $0.01 | +4,259 | 106.2K | +4% | +$42.59 |
| D | 2021-08-11 | 2021-08-10 | STTK | Pandite Arundathy N. | Chief Medical Off | M - OptEx | $0.00 | -4,259 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | M | A | 4,259 | $0.01 | 106,166 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-08-10 | M | D | 4,259 | $0.00 | 0 | D | $0.01 · — to 2027-12-21 | 4,259 Common Stock | (F1) This option represented a right to purchase a total of 5,863 shares of the Issuer's common stock and has vested in full. |